FindTrial
Sign In

The role and molecular mechanism of m6A methyltransferase KIAA1429 in promoting cuproptosis through epigenetic regulation of FDX1 in endometrial cancer progression

The role and molecular mechanism of m6A methyltransferase KIAA1429 in promoting cuproptosis through epigenetic regulation of FDX1 in endometrial cancer progression

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114300
Enrollment
Unknown
Registered
2025-12-10
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cancer

Interventions

Control group and experimental group:None

Sponsors

The First Affiliated Hospital of Ningbo University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Pathological diagnosis endometrial carcinoma;

Exclusion criteria

Exclusion criteria: 1.with another tumor;

Design outcomes

Primary

MeasureTime frame
Expression;—

Countries

China

Contacts

Public ContactShi Hongyan

The First Affiliated Hospital of Ningbo University

810586974@qq.com+86 574 87085210

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026